Manufacturers

Drug development checklist: what to look for in a commercialization partner

Manufacturers

Pre-launch checklist: what to look for in a commercialization partner

Manufacturers

Post launch checklist: what to look for in a commercialization partner

Manufacturers

InnomarLive 2023: Part One

Manufacturers

InnomarLive 2023: Part Two

Manufacturers

InnomarLive 2023: Part Three

Manufacturers

Reuters Cell & Gene Therapy USA 2022 – RWE for Market Access

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Manufacturers

The value of Real-World Evidence in Canadian drug commercialization: Part 2

Manufacturers

Webinar: 2020 pan-Canadian Oncology Drug Review (pCODR) Updates

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Manufacturers

Market Access: Negotiations

Manufacturers

Market Access: Reimbursement

Manufacturers

Market Access: Pricing

Manufacturers

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Manufacturers

InnomarLive 2019: Commercializing in Canada

Infographic: The Route to Market Access in Canada

Infographic: The Road to Commercialization in Canada

Insight Series: Biosimilars in Canada

Future of Patient Support Programs in Canada